Nova Anchora
- Business Model
- B2B
- Website
- novaanchora.com
About
Biopharmaceutical company developing protein therapy for epidermolysis bullosa, a rare genetic skin disease.
Similar Companies
inVentiv HealthAcquired
Biopharmaceutical services company
United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
WC
Warner ChilcottAcquired
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
AsymchemIPO
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020
Hugel
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Chuncheon, South Korea201–500Aesthetics, Biotech
Private Equity·$2.3B·Aug 2021
N
Novotech
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Sydney, Australia1001–5000Biotech, Healthcare
Growth Equity·$1.9B·Mar 2025
Celerion (H.I.G. Capital)
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Lincoln, United States501–1000Biotech, Healthcare
Private Equity·$1.8B·Apr 2026